← Back to Vaccine Database

Nasovac-S

Live attenuated vaccine · VDDBV0546

Target & Classification

InfluenzaInfluenza virus
Live attenuated vaccine
Influenza
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT02972957 ApprovedInfluenza